2van der Zee J. Heating the patient: a promising approach?Ann Oncol,2002,13(8) :1 173.
3Westermann AM, Grosen EA, Katschinski DM,et al. A pilot study of whole body hyperthermia and carboplatin in platinumresistant ovarian cancer. Eur J Cancer,2001,37 (9) : 1 111.
4Van Heek-Romanowski R, Putter S ,Trarbach T,et al. Etoposide toxicity on human neuroblastoma cells in vitro is enhanced by preceeding hyperthermia. Med Pediatr Oncol,2001,36(1 ) :197.
5Monge OR, Rofstad EK, Kaalhus O. Thermochemotherapy in vivo of a C3H mouse mammary carcinoma: sinigle fraction heat and drug treatment. Eur J Cancer Clin Oncol, 1988,24(10) :1 661.
6Stein U, Jurchott K, Walther W, et al. Hyperthermia induced nuclear translocation of transcription factor YB-1 leads to enhanced expression of multidrug resistance-related ABC transporters. J Biol Chem, 2001,276(30) :28 562.
7Pazdur R, Kudelka AP, Kavanagh JJ, et al. The taxoids:pacli-taxel (taxol) and docetaxel (taxotere). Cancer Treat Rev,1993,19(4) :351.
8Perez EA, Buckwalter CA, Reid JP. Combinations of paclitaxel and etoposide in the treatment of lung cancer. Semin Oncol, 1996,23(6 Suppl 15) :21.
9Donehower RC, Rowinsky EK, Grochow LB, et al. Phase I trial of taxol in patients with advanced cancer. Cancer Treat Rep,1987,71 (12) :1 171.
10Jordan MA,Toso RJ,Thrower D,et al. Mechanism of mitotic block and inhibitor of cell proliferation by taxol at low concentration. Proc Natl Acad Sci USA,1993,90(20) :9 552.
